Cargando…

Negative (18)F-FET PET/CT in brain metastasis recurrence: a teaching case report

Positron emission tomography (PET) using O-(2-[(18)F]fluoroethyl)-L-tyrosine ((18)F-FET) PET has been shown to be a useful tool for differentiating radiation therapy outcomes, such as brain metastasis recurrence or radiation necrosis. We present the case of a female patient with brain metastases fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshehri, Samirah, Prior, John, Moshebah, Mohammed, Schiappacasse, Luis, Dunet, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606481/
https://www.ncbi.nlm.nih.gov/pubmed/34806124
http://dx.doi.org/10.1186/s41824-021-00115-0
Descripción
Sumario:Positron emission tomography (PET) using O-(2-[(18)F]fluoroethyl)-L-tyrosine ((18)F-FET) PET has been shown to be a useful tool for differentiating radiation therapy outcomes, such as brain metastasis recurrence or radiation necrosis. We present the case of a female patient with brain metastases from pulmonary mucinous adenocarcinoma with suspicion of tumor recurrence on follow-up magnetic resonance imaging (MRI) after radiosurgery. (18)F-FET PET/computed tomography (CT) was indicative of radiation necrosis. Due to the patient's medical history and the discrepancy between the brain MRI and PET/CT results, surgical biopsies were decided, which were positive for brain metastasis recurrence. The diagnosis of metastasis recurrence may also be challenging on (18)F-FET PET/CT. In case of discrepancies between MRI and PET/CT results, false-negative (18)F-FET PET/CT remains a possibility and requires careful follow-up or biopsy.